3.0
2 Feb 2026
Former employee, more than 3 years
Recommend
CEO approval
Business outlook
Pros
Great Team, Great Product, Solid Science & product. DEI program is fantastic.
Cons
Eurofins' management of Transplant Genomics and the Diagnostic arm of their testing is very poor. Decisions are made with the bottom line in mind and not of the product or longevity. 2 Major RIFs in 3 years. Paying 20% under going rate across the board.